Transgene appoints Prof. Antoine Italiano, MD, PhD, and Prof. Ignacio Melero, MD, PhD, as key scientific advisors to its Scientific Advisory Board. They bring expertise in precision medicine, immune-oncology, and cancer immunotherapy to accelerate the development of myvac® and other viral vector-based cancer vaccine candidates. Prof. Italiano specializes in early drug development and precision medicine, leading research in immuno-oncology and rare tumors. Prof. Melero is known for his work in cancer immunotherapy and has led numerous clinical trials in immunotherapy. Both advisors will strengthen Transgene’s scientific leadership in developing targeted immunotherapies for cancer treatment.

Read more at GlobeNewswire: Transgene Further Strengthens Scientific Advisory Board